(Q28483956)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

The International Classification of Headache Disorders: 2nd edition

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Headache: one of the most common and troublesome adverse reactions to drugs

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Epidemiology and comorbidity of headache

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Under-reporting of adverse drug reactions : a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Improving safety reporting from randomised trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Migraine with aura after administration of sublingual nitroglycerin tablets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Epidemiological assessment of drug-induced disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Adverse drug reactions: definitions, diagnosis, and management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Counting the costs of drug-related adverse events

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Problems assessing nonserious adverse drug reactions: antidepressant drug therapy and sexual dysfunction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Methods for monitoring and documenting adverse drug reactions.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Cyclosporin associated headache

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Idiosyncratic drug reactions: a mechanistic evaluation of risk factors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Migraine with typical aura associated with fluoxetine therapy: case report

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451740

Reporting results of cancer treatment

2 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Adverse drug reaction reporting by patients in the Netherlands: three years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Women encounter ADRs more often than do men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Phosphodiesterase-5 inhibitors and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Migraines linked to interferon-beta treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Migraine-type headaches in children receiving chemotherapy and ondansetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

21 January 2018

Migraine and sertraline

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Sildenafil can trigger cluster headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Nitroglycerin-Induced Headache is Not Dependent on Histamine Release: Support For a Direct Nociceptive Action of Nitric Oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Dipyridamole May Induce Migraine in Patients With Migraine Without Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-009-0127-1

Nitrolglycerin as a provocative agent in cluster headache

21 January 2018

1 reference

12 December 2020

Adverse drug reactions and polypharmacy in the elderly in general practice

1 reference

12 December 2020

MEDWatch: the new FDA medical products reporting program

1 reference

12 December 2020

International drug monitoring. The role of the hospital

1 reference

12 December 2020

Prescription-event monitoring and reporting of adverse drug reactions

1 reference

12 December 2020

Tadalafil associated with typical migraine aura without headache

1 reference

12 December 2020

Safety reporting in clinical trials

1 reference

12 December 2020